SELLAS Life Sciences Group, Inc.
SLS
$6.47
$1.2523.85%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.66M | -6.79M | -6.60M | -5.81M | -6.74M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 601.00K | 650.00K | 650.00K | 652.00K | 521.00K |
| Change in Net Operating Assets | 2.14M | -927.00K | -1.38M | -3.91M | -937.00K |
| Cash from Operations | -4.92M | -7.07M | -7.33M | -9.07M | -7.15M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.91M | 4.06M | 4.23M | 23.58M | 72.00K |
| Repurchase of Common Stock | -527.00K | -- | -- | -- | -64.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 29.02M | 22.03M | -- | -- | -- |
| Cash from Financing | 32.39M | 26.09M | 4.23M | 23.58M | 8.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 27.47M | 19.02M | -3.10M | 14.51M | -7.15M |